[go: up one dir, main page]

Liu et al., 2018 - Google Patents

Aptamer and IR820 dual‐functionalized carbon dots for targeted cancer therapy against hypoxic tumors based on an 808 nm laser‐triggered three‐pathway strategy

Liu et al., 2018

Document ID
3663384853968248202
Author
Liu R
Zhang L
Zhao J
Luo Z
Huang Y
Zhao S
Publication year
Publication venue
Advanced Therapeutics

External Links

Snippet

As a typical characteristic of solid tumors, hypoxia diminishes the efficiency of oxygen‐ dependent cancer therapy, such as type II photodynamic therapy (PDT). Tumor‐targeted multifunctional nanomedicine that overcomes hypoxic resistance is therefore highly …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy

Similar Documents

Publication Publication Date Title
Liu et al. Aptamer and IR820 dual‐functionalized carbon dots for targeted cancer therapy against hypoxic tumors based on an 808 nm laser‐triggered three‐pathway strategy
Cheng et al. Spatiotemporally synchronous oxygen self‐supply and reactive oxygen species production on Z‐scheme heterostructures for hypoxic tumor therapy
Guo et al. Synthesis of BSA‐coated BiOI@ Bi2S3 semiconductor heterojunction nanoparticles and their applications for radio/photodynamic/photothermal synergistic therapy of tumor
Yang et al. Conferring BiVO4 nanorods with oxygen vacancies to realize enhanced sonodynamic cancer therapy
Sun et al. Ce6-modified carbon dots for multimodal-imaging-guided and single-NIR-laser-triggered photothermal/photodynamic synergistic cancer therapy by reduced irradiation power
Lan et al. Carbon dots as multifunctional phototheranostic agents for photoacoustic/fluorescence imaging and photothermal/photodynamic synergistic cancer therapy
Gao et al. Hyperthermia‐triggered on‐demand biomimetic nanocarriers for synergetic photothermal and chemotherapy
Qi et al. Photosynthetic cyanobacteria‐hybridized black phosphorus nanosheets for enhanced tumor photodynamic therapy
Jia et al. A magnetofluorescent carbon dot assembly as an acidic H2O2‐driven oxygenerator to regulate tumor hypoxia for simultaneous bimodal imaging and enhanced photodynamic therapy
Guo et al. A porphyrin‐based conjugated polymer for highly efficient in vitro and in vivo photothermal therapy
Tian et al. Red‐Emitting upconverting nanoparticles for photodynamic therapy in cancer cells under near‐infrared excitation
Wang et al. All‐in‐one phototheranostics: single laser triggers NIR‐II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy
Yang et al. 1D coordination polymer nanofibers for low‐temperature photothermal therapy
Song et al. Low‐dose X‐ray activation of W (VI)‐doped persistent luminescence nanoparticles for deep‐tissue photodynamic therapy
Wang et al. Nanosonosensitization by using copper–cysteamine nanoparticles augmented sonodynamic cancer treatment
Liu et al. All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication
Zhang et al. Light-enhanced hypoxia-response of conjugated polymer nanocarrier for successive synergistic photodynamic and chemo-therapy
Chan et al. Minimizing the heat effect of photodynamic therapy based on inorganic nanocomposites mediated by 808 nm near‐infrared light
Ma et al. A new X-ray activated nanoparticle photosensitizer for cancer treatment
Gao et al. Near‐infrared light responsive imaging‐guided photothermal and photodynamic synergistic therapy nanoplatform based on carbon Nanohorns for efficient cancer treatment
Ju et al. Tumor microenvironment activated photothermal strategy for precisely controlled ablation of solid tumors upon NIR irradiation
Wang et al. Metal–Organic‐framework‐derived mesoporous carbon nanospheres containing porphyrin‐like metal centers for conformal phototherapy
Wang et al. Imaging‐guided pH‐sensitive photodynamic therapy using charge reversible upconversion nanoparticles under near‐infrared light
Hu et al. Indocyanine green-loaded polydopamine-reduced graphene oxide nanocomposites with amplifying photoacoustic and photothermal effects for cancer theranostics
Zheng et al. Biodegradable natural product-based nanoparticles for near-infrared fluorescence imaging-guided sonodynamic therapy